Publications

Nardone, A; Pebody, RG; Van den Hof, S; Levy-Bruhl, D; Plesner, AM; Rota, MC; Tischer, A; Andrews, N; Berbers, G; Crovari, P; EDMUNDS, WJ; Gabutti, G; Saliou, P; MILLER, E;

2003

Epidemiology and infection, (2003).131 1 10.1017/s0950268803008768.

Maternal immunisation in developing countries.

GREENWOOD, B;

2003

Vaccine, (2003).21 24 10.1016/s0264-410x(03)00346-3.

Gamma interferon responses induced by a panel of recombinant and purified mycobacterial antigens in healthy, non-mycobacterium bovis BCG-vaccinated Malawian young adults.

Black, GF; Weir, RE; Chaguluka, SD; Warndorff, D; CRAMPIN, AC; Mwaungulu, L; Sichali, L; FLOYD, S; Bliss, L; Jarman, E; Donovan, L; Andersen, P; Britton, W; Hewinson, G; Huygen, K; Paulsen, J; Singh, M; Prestidge, R; FINE, PE M; DOCKRELL, HM;

2003

Clinical and diagnostic laboratory immunology, (2003).10 4 10.1128/cdli.10.4.602-611.2003.

Caution--mortality ratios ahead.

CUTTS, FT; FINE, PE M;

2003

Lancet, (2003).361 9376 10.1016/s0140-6736(03)13783-x.

The infectious intestinal disease study of England: a prospective evaluation of symptoms and health care use after an acute episode.

Cumberland, P; Sethi, D; Roderick, PJ; Wheeler, JG; Cowden, JM; Roberts, JA; RODRIGUES, LC; Hudson, MJ; Tompkins, DS; IID Study Executive,;

2003

Epidemiology and infection, (2003).130 3 10.1017/s0950268803008410.

The predicted impact of private sector MMR vaccination on the burden of Congenital Rubella Syndrome.

VYNNYCKY, E; Gay, NJ; Cutts, FT;